ISDA

Entry Detail

PDB ID:

3G7B

Keywords:

Title:

Staphylococcus aureus Gyrase B co-complex with METHYL ({5-[4-(4-HYDROXYPIPERIDIN-1-YL)-2-PHENYL-1,3-THIAZOL-5-YL]-1H-PYRAZOL-3-YL}METHYL)CARBAMATE inhibitor

Biological Source:

Source Organism:

Staphylococcus aureus

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2009-02-09

Release Date:

2010-02-09

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.27

R-Value Work:

0.20

R-Value Observed:

0.21

Space Group:

C 1 2 1

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:DNA gyrase subunit B
Mutations:deletion, residues 105-127
Chain IDs:A, B
Chain Length:184
Number of Molecules:2
Biological Source:Staphylococcus aureus

UniProt ID:P0A0K8 Pfam ID:PF02518 EC:5.6.2.2

Ligand Molecules

B47

Primary Citation

Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.

Ronkin, S.M, Badia, M, Bellon, S, Grillot, A.L, Gross, C.H, Grossman, T.H, Mani, N, Parsons, J.D, Stamos, D, Trudeau, M, Wei, Y, Charifson, P.S.Show

Bioorg.Med.Chem.Lett. 20 2828 2831 (2010)

PMID: 20356737 DOI: 10.1016/j.bmcl.2010.03.052

Abstact

Bacterial DNA gyrase is an attractive target for the investigation of new antibacterial agents. Inhibitors of the GyrB subunit, which contains the ATP-binding site, are described in this communication. Novel, substituted 5-(1H-pyrazol-3-yl)thiazole compounds were identified as inhibitors of bacterial gyrase. Structure-guided optimization led to greater enzymatic potency and moderate antibacterial potency. Data are presented for the demonstration of selective enzyme inhibition of Escherichia coli GyrB over Staphylococcus aureus GyrB.

Legend

Protein

Chemical

Disease

Primary Citation of related structures